MaureenFay(Fay)MccarthyMD

PubMed

• 6 citations
  Management of schizophrenia with medical disorders: cardiovascular, pulmonary, and gastrointestinal.
  Delmar D. Short, Joanne M. Hawley, Maureen F. McCarthy> ;The Psychiatric Clinics of North America. 2009 Dec 1
• 50 citations
  Methylene blue adjuvant therapy of schizophrenia.
  Stephen I. Deutsch, Richard B. Rosse, Barbara L. Schwartz, Maureen Fay-McCarthy, Paul B. Rosenberg, Kim Fearing> ;Clinical Neuropharmacology. 1997 Aug 1
• 20 citations
  Effects of nifedipine, a calcium channel antagonist, on cognitive function in schizophrenic patients with tardive dyskinesia.
  Barbara L. Schwartz, Maureen Fay-McCarthy, Kathleen A. Kendrick, Richard B. Rosse, Stephen I. Deutsch> ;Clinical Neuropharmacology. 1997 Aug 1
• 45 citations
  D-cycloserine adjuvant therapy to molindone in the treatment of schizophrenia.
  Richard B. Rosse, Maureen Fay-McCarthy, Kathleen A. Kendrick, R. E. Davis, S.I. Deutsch> ;Clinical Neuropharmacology. 1996 Oct 1
• 27 citations
  An open-label study of the therapeutic efficacy of high-dose famotidine adjuvant pharmacotherapy in schizophrenia: preliminary evidence for treatment efficacy.
  Richard B. Rosse, Kathie Kendrick, Maureen Fay-McCarthy, George D. Prell, Paul B. Rosenberg, Lorraine C. Tsui, Richard Jed Wyatt, Stephen I. Deutsch> ;Clinical Neuropharmacology. 1996 Aug 1
• 1 citations
  Smooth pursuit eye movements in the evaluation of famotidine adjunctive therapy of schizophrenia: a preliminary report.
  Paul B. Rosenberg, Richard B. Rosse, Surendra K. Johri, Kathie Kendrick, Maureen Fay-McCarthy, Joseph P. Collins, Lorraine C. Tsui, Richard Jed Wyatt, Stephen I. Deutsch> ;Clinical Neuropharmacology. 1996 Jun 1
• 12 citations
  Famotidine adjunctive pharmacotherapy of schizophrenia: A case report
  Richard B. Rosse, Kathie Kendrick, Lorraine C. Tsui, Maureen Fay-McCarthy, Joseph P. Collins, Paul B. Rosenberg, Richard Jed Wyatt, S.I. Deutsch> ;Clinical Neuropharmacology. 1995 Aug 1
• 15 citations
  The relationship between cocaine‐induced paranoia and compulsive foraging: a preliminary report
  Richard B. Rosse, Maureen Fay‐Mccarthy, Joseph P. Collins, Tanya N. Alim, Stephen I. Deutsch> ;Addiction. 1994 Sep 1
• 17 citations
  Nimodipine pharmacotherapeutic adjuvant therapy for inpatient treatment of cocaine dependence.
  Richard B. Rosse, Tanya N. Alim, Maureen Fay-McCarthy, Joseph P. Collins, Frank Vocci, Teresa Lindquist, Cathleen Jentgen, Anemarie L. Hess, Stephen I. Deutsch> ;Clinical Neuropharmacology. 1994 Aug 1
• 39 citations
  Phenomenologic comparison of the idiopathic psychosis of schizophrenia and drug-induced cocaine and phencyclidine psychoses: a retrospective study.
  Richard B. Rosse, Joseph P. Collins, Maureen Fay-McCarthy, Tanya N. Alim, Richard Jed Wyatt, Stephen I. Deutsch> ;Clinical Neuropharmacology. 1994 Aug 1
• 9 citations
  Saccadic distractibility in cocaine dependent patients: A preliminary laboratory exploration of the cocaine-OCD hypothesis
  Richard B. Rosse, Maureen Fay McCarthy, Tanya N. Alim, Stephen I. Deutsch> ;Drug and Alcohol Dependence. 1994 Mar 1
• 9 citations
  L-tyrosine pharmacotherapy of schizophrenia: preliminary data.
  Stephen I. Deutsch, Richard B. Rosse, Barbara L. Schwartz, Miriam Banay-Schwartz, Maureen Fay McCarthy, Surendra K. Johri> ;Clinical Neuropharmacology. 1994 Feb 1
• 22 citations
  Famotidine adjunctive pharmacotherapy for schizophrenia: preliminary data.
  Stephen I. Deutsch, Richard B. Rosse, Kathleen A. Kendrick, Maureen Fay-McCarthy, Joseph P. Collins, Richard Jed Wyatt> ;Clinical Neuropharmacology. 1993 Dec 1
• 33 citations
  Transient compulsive foraging behavior associated with crack cocaine use
  Richard B. Rosse, M. Fay-McCarthy, J.P. Collins, Risher-Flowers D, Alim Tn, Stephen I. Deutsch> ;The American Journal of Psychiatry. 1993 Jan 1
• Join now to see all